Rio Tinto plc Stock Price Slips as Glencore Deal Hopes Return, Kennecott Shutdown Adds Fresh Risk

Rio Tinto plc Stock Price Slips as Glencore Deal Hopes Return, Kennecott Shutdown Adds Fresh Risk

March 13, 2026

London, March 13, 2026, 14:00 GMT

Rio Tinto stock dipped in London, down about 0.7% near 6,800 pence by 10:50 GMT on Friday. Glencore circling for renewed merger talks added another layer of uncertainty, while Rio’s Kennecott copper mine halted operations after a worker fatality. Bloomberg

Right now, Rio shares are being pulled by two forces: anticipation over a possible deal and jitters about operational risks. Glencore’s side argues that stronger coal prices give them more leverage, but under the UK Takeover Code—which triggers a six-month standstill after talks break down—Rio won’t be able to restart official discussions until August. Reuters

Coal has rallied 26% since Jan. 7, taking Glencore’s stock up by the same margin. Rio’s shares, on the other hand, are up just 9%. Glencore now claims it should account for roughly 35% of a merged company—an increase from the earlier 31.5%—based on comments from three investors after meetings with executives in Australia this week. Both Rio and Glencore wouldn’t comment on those talks. Reuters

Rio made it clear it wouldn’t go any further. When negotiations broke down last month, Chief Executive Simon Trott said, “Ultimately we formed the view that we couldn’t stand up a value case, and that’s where it stands.” Merging the companies would have put them on top as the world’s largest miner, overtaking BHP. Reuters

Kennecott is facing fresh scrutiny. Rio Tinto halted both above- and below-ground mining at its Utah operation following a contractor fatality on Thursday. “The safety of our people comes before everything else,” Trott said. Reuters notes the mine ranks among the world’s leading copper sources. Rio Tinto

The timing stings for Rio, which has been pushing to diversify away from iron ore. Just this week, it joined Prysmian to test low-carbon aluminium cables aimed at data centres. And in Brazil, the antitrust regulator signed off on Rio and Chinalco’s deal to snap up a controlling stake in aluminium maker CBA, giving the go-ahead with no strings attached. Rio Tinto

Investor skepticism around a Glencore deal was clear early on—coal, along with ESG concerns, drove much of the hesitation. RBC’s Kaan Peker flagged in January that reintroducing coal would be “unacceptable” for a big chunk of Rio’s European base. John Ayoub at Wilson Asset Management saw an Australian nod only if coal got spun off. Tim Hillier over at Allan Gray, meanwhile, cautioned Rio risked paying too much. Reuters

Still, a swift rebound for the stock seems unlikely. For any Glencore tie-up to come back to life, the company would have to clear hurdles from shareholders, regulators, and government bodies. Back in January, five Australian funds had already flagged governance issues in a letter to Rio’s board, citing Glencore’s record of past corruption investigations. On top of that, Rio hasn’t set out any timeline for bringing Kennecott back online. Reuters

Investors aren’t biting on fresh merger rumors just yet—they’re holding out for something concrete. On Friday, share moves pointed to mine headlines and commodity numbers taking the front seat, with speculation on deals trailing behind. Bloomberg

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Pro Medicus Stock Soars Post Echo IQ Deal, Valued at A$1 Billion
    June 26, 2026, 4:15 PM EDT. Pro Medicus (ASX:PME) closed at A$188.88 on June 26, rising 1.9% on the day and 9.3% over the week, fueled by a deal with Echo IQ (ASX:EIQ) valued at A$20 million but generating an effective market cap increase of approximately A$1.03 billion. This deal involves a proposed U.S. reseller agreement for EchoSolv AI tools, with final legal documents expected within 20 business days. Echo IQ will receive A$10 million in secured convertible notes initially, paying 12.5% interest, secured by AI cardiovascular algorithms. The surge reflects investor confidence in Pro Medicus leveraging Visage 7 Cardiology software to expand into AI distribution. Despite being dropped from the S&P/ASX 50 index, the stock gains suggest strong sector interest amid broader market stagnation.